United States Biotechnology & Medical Research

Cypherpunk Technologies Inc (CYPH)

Cypherpunk Technologies Inc. experienced four insider trading transactions over the past ninety days, all involving sales totaling approximately 888,900 USD. These divestments occurred amid a significant 419.6% stock price increase. No executive buying activity was recorded following the most recent earnings report, reflecting a period of consistent liquidation by key stakeholders.
Ticker: CYPH Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cypherpunk Technologies Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Oei Khing Djien Non-Executive Director
Transaction date
Sale
Price
258.34
Quantity 75,817 +16.3%
Value US$3,416,417
Martin Patricia A. Non-Executive Director
Transaction date
Sale
Price
160.37
Quantity 14,972 +23.7%
Value US$3,821,941
1.5
Dietz Thomas John Non-Executive Director
Transaction date
Sale
Price
416.38
Quantity 93,760 +32.6%
Value US$888,494
1.5
Dietz Thomas John Director Non-Executive Director
Transaction date
Proposed sale
Price
1.62
Quantity 20,000
Value US$32,300
3.7
Mirabelli Christopher Non-Executive Director
Transaction date
Sale
Price
0.71
Quantity 60,000 -31.5%
Value US$42,630
3.7
CHRISTOPHER MIRABELLI Director Non-Executive Director
Transaction date
Proposed sale
Price
0.71
Quantity 60,000
Value US$42,629
3.7
Mirabelli Christopher Non-Executive Director
Transaction date
Sale
Price
3.14
Quantity 414,479 -99.5%
Value US$1,301,464
3.7
Mirabelli Christopher Non-Executive Director
Transaction date
Sale
Price
3.14
Quantity 261,840 -38.6%
Value US$822,178
3.4
ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.&Sec. Executive Director
Transaction date
Sale
Price
3.14
Quantity 414,479 -99.5%
Value US$1,301,464
3.4
ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.&Sec. Executive Director
Transaction date
Sale
Price
3.14
Quantity 261,840 -38.6%
Value US$822,178
3.4
CAVANAUGH JAMES H Non-Executive Director
Transaction date
Sale
Price
3.14
Quantity 261,840 -100.0%
Value US$822,178
BeiGene, Ltd. Large shareholder
Transaction date
Purchase
Price
2.85
Quantity 2,543,800 +52.9%
Value US$7,249,830
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
2.00
Quantity 1,750,000 +26.0%
Value US$3,500,000
3.4
LAWLOR AUGUSTINE Chief Operating Officer Officer Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 571,428 +16.1%
Value US$999,999
3.4
ONSI DOUGLAS E CFO, GC, Treasurer & Secretary Officer Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 571,428 +16.1%
Value US$999,999
3.7
Mirabelli Christopher CEO, President, Chairman Executive Director Large shareholder
Transaction date
Purchase
Price
1.75
Quantity 571,428 +16.1%
Value US$999,999
3.0
Mirabelli Christopher CEO, President, COB Executive Director Large shareholder
Transaction date
Purchase
Price
6.09
Quantity 1,057,769 +42.0%
Value US$6,436,524
3.4
LAWLOR AUGUSTINE Chief Operating Officer Large shareholder
Transaction date
Purchase
Price
6.09
Quantity 1,057,769 +42.0%
Value US$6,436,524
HealthCare Ventures IX, L.P. Large shareholder
Transaction date
Purchase
Price
6.09
Quantity 1,057,769 +42.0%
Value US$6,436,524
ONSI DOUGLAS E CFO, GC, Treasurer & Secretary Large shareholder
Transaction date
Purchase
Price
6.09
Quantity 1,057,769 +42.0%
Value US$6,436,524
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-25 2026-09-25 S Sale
Oei Khing Djien
Non-Executive Director
75,817 +16.3%
258.34
US$3,416,417 		75,817 +16.3% 258.34 US$3,416,417
2026-09-25 2026-09-23 S Sale
Martin Patricia A.
Non-Executive Director
14,972 +23.7%
160.37
US$3,821,941 		14,972 +23.7% 160.37 US$3,821,941
2026-08-27 2026-08-26 S Sale
1.5
Dietz Thomas John
Non-Executive Director
93,760 +32.6%
416.38
US$888,494 		93,760 +32.6% 416.38 US$888,494
2026-08-26 2026-08-26 PrS Proposed sale
1.5
Dietz Thomas John

Director

Non-Executive Director
20,000
1.62
US$32,300 		20,000 1.62 US$32,300
2026-03-30 2026-03-26 S Sale
3.7
Mirabelli Christopher
Non-Executive Director
60,000 -31.5%
0.71
US$42,630 		60,000 -31.5% 0.71 US$42,630
2026-03-27 2026-03-26 PrS Proposed sale
3.7
CHRISTOPHER MIRABELLI

Director

Non-Executive Director
60,000
0.71
US$42,629 		60,000 0.71 US$42,629
2025-11-19 2025-11-17 S Sale
3.7
Mirabelli Christopher
Non-Executive Director
414,479 -99.5%
3.14
US$1,301,464 		414,479 -99.5% 3.14 US$1,301,464
2025-11-19 2025-11-17 S Sale
3.7
Mirabelli Christopher
Non-Executive Director
261,840 -38.6%
3.14
US$822,178 		261,840 -38.6% 3.14 US$822,178
2025-11-19 2025-11-17 S Sale
3.4
ONSI DOUGLAS E

CEO,CFO,Pres.,GC,Treas.&Sec.

Executive Director
414,479 -99.5%
3.14
US$1,301,464 		414,479 -99.5% 3.14 US$1,301,464
2025-11-19 2025-11-17 S Sale
3.4
ONSI DOUGLAS E

CEO,CFO,Pres.,GC,Treas.&Sec.

Executive Director
261,840 -38.6%
3.14
US$822,178 		261,840 -38.6% 3.14 US$822,178
2025-11-19 2025-11-17 S Sale
3.4
CAVANAUGH JAMES H
Non-Executive Director
261,840 -100.0%
3.14
US$822,178 		261,840 -100.0% 3.14 US$822,178
2021-09-28 2021-09-24 B Purchase
BeiGene, Ltd.
Large shareholder
2,543,800 +52.9%
2.85
US$7,249,830 		2,543,800 +52.9% 2.85 US$7,249,830
2020-06-24 2020-06-22 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
1,750,000 +26.0%
2.00
US$3,500,000 		1,750,000 +26.0% 2.00 US$3,500,000
2019-02-05 2019-02-05 B Purchase
3.4
LAWLOR AUGUSTINE

Chief Operating Officer

Officer Large shareholder
571,428 +16.1%
1.75
US$999,999 		571,428 +16.1% 1.75 US$999,999
2019-02-05 2019-02-05 B Purchase
3.4
ONSI DOUGLAS E

CFO, GC, Treasurer & Secretary

Officer Large shareholder
571,428 +16.1%
1.75
US$999,999 		571,428 +16.1% 1.75 US$999,999
2019-02-05 2019-02-05 B Purchase
3.7
Mirabelli Christopher

CEO, President, Chairman

Executive Director Large shareholder
571,428 +16.1%
1.75
US$999,999 		571,428 +16.1% 1.75 US$999,999
2019-02-05 2019-02-05 B Purchase
HealthCare Ventures IX, L.P.
Large shareholder
571,428 +16.0%
1.75
US$999,999 		571,428 +16.0% 1.75 US$999,999
2017-11-16 2017-11-14 B Purchase
3.0
Mirabelli Christopher

CEO, President, COB

Executive Director Large shareholder
1,057,769 +42.0%
6.09
US$6,436,524 		1,057,769 +42.0% 6.09 US$6,436,524
2017-11-16 2017-11-14 B Purchase
3.4
LAWLOR AUGUSTINE

Chief Operating Officer

Large shareholder
1,057,769 +42.0%
6.09
US$6,436,524 		1,057,769 +42.0% 6.09 US$6,436,524
2017-11-16 2017-11-14 B Purchase HealthCare Ventures IX, L.P. Large shareholder
1,057,769 +42.0%
6.09
US$6,436,524 		1,057,769 +42.0% 6.09 US$6,436,524
2017-11-16 2017-11-14 B Purchase ONSI DOUGLAS E

CFO, GC, Treasurer & Secretary

Large shareholder
1,057,769 +42.0%
6.09
US$6,436,524 		1,057,769 +42.0% 6.09 US$6,436,524
Explore more

More insider trading research around Cypherpunk Technologies Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America